Benefits
Blood Pressure Reduction in Hypertension
Pharmactive 2023 RCT (Hospital Universitari Arnau de Vilanova, n=81 Grade-1 hypertensive patients on prescribed BP medication, 12 weeks) showed ABG10+ produced significant blood pressure reductions vs placebo. Adjunct effect to standard antihypertensive therapy.
Diastolic Blood Pressure in Hypercholesterolemia
2022 crossover trial in moderately hypercholesterolemic patients (PMC8838962) showed ABG+ produced 5.85 mmHg average reduction in diastolic blood pressure vs placebo over 6 weeks.
Lipid Profile / HDL Functionality
Recent (2026) NMR spectroscopy study in 75 Grade-1 hypertensive patients showed 12 weeks ABG supplementation enhanced HDL functionality markers and reduced cholesterol load in large VLDL particles. Quality improvements in lipoprotein subclasses.
Nitric Oxide and Antioxidant Capacity
Mechanism studies showed ABG10+ enhances nitric oxide release and elevates body's antioxidant capability — foundation for vascular health effects.
ACE Activity Reduction
Reduction in angiotensin-converting enzyme (ACE) activity — same target as ACE inhibitor medications. Mechanism for blood pressure effects.
Alternative to Red Yeast Rice
Pharmactive positions ABG10+ as alternative to red yeast rice for cardioprotection — without monacolin K regulatory concerns or statin-like side effects.
Mechanism of action
Aging Process Bioactive Concentration
Proprietary controlled-temperature aging transforms white garlic into black garlic — fresh sulfur compounds (allicin) undergo chemical changes forming new compounds: S-allyl cysteine (SAC), melanoidins, distinctive flavor/color compounds. Same process traditionally used in Korean/Japanese cooking; Pharmactive industrialized for standardization.
S-Allyl Cysteine (SAC) Activity
SAC is the most-studied bioactive in aged black garlic. More stable, water-soluble, and bioavailable than allicin (fresh garlic compound). Antioxidant, anti-inflammatory, vasodilatory effects.
Nitric Oxide Pathway Modulation
Increases nitric oxide release in vascular endothelium — vasodilation and improved blood flow. Foundation for blood pressure effects.
ACE Inhibition (Modest)
Reduces angiotensin-converting enzyme activity — same target as ACE inhibitor medications (lisinopril, enalapril); modest effect, additive to medications.
Antioxidant Polyphenol Profile
Polyphenols, flavonoids, and melanoidins formed during aging provide direct antioxidant activity protecting vascular tissue.
Clinical trials
Randomized triple-blind controlled trial of ABG10+ in 81 Grade-1 hypertensive patients receiving prescribed BP medication for 12 weeks. Published in Nutrients.
81 Grade-1 hypertensive patients on prescribed BP medication.
Significant reduction in blood pressure vs placebo. Established ABG10+ as adjunct to standard hypertension therapy.
Randomized crossover double-blind trial of ABG+ (250 mg, 1.25 mg SAC daily) in moderately hypercholesterolemic patients for 6 weeks per arm.
Moderately hypercholesterolemic adults.
5.85 mmHg average reduction in diastolic blood pressure vs placebo. Established cardiovascular adjunct evidence.
Randomized triple-blind placebo-controlled trial of 250 mg ABG10+ daily in 75 Grade-1 hypertensive participants for 12 weeks; lipoprotein subclasses analyzed by NMR spectroscopy.
75 Grade-1 hypertensive participants.
Enhanced HDL functionality markers; reduced cholesterol load in large VLDL particles; specific qualitative lipoprotein improvements suggesting cardiovascular benefit beyond simple LDL reduction.